HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ODS Supplement Label Database Nears Launch, Targets Helping Research

This article was originally published in The Tan Sheet

Executive Summary

The Office of Dietary Supplements will roll out an online database starting with labels for about 18,000 current supplement products, replacing a smaller database maintained by NIH’s Library of Medicine.

You may also be interested in...



Durbin Bill Would Narrow Definition Of Dietary Supplement

Legislation Sen. Dick Durbin offers to stop firms from allegedly side-stepping food safety standards by labeling products as dietary supplements could have a "devastating impact on the industry," stakeholders say.

ODS Expects Positive Impact On Industry From Promoting Supplement Science

The National Institutes of Health's Office of Dietary Supplements does not operate to promote supplement products, but shares a common interest with industry that can help spur businesses' growth - disseminating information and improving research, says ODS Director Paul Coates

NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building

NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS124370

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel